Description

Selective growth hormone secretagogue

Ipamorelin is a highly selective GHRP that activates the pituitary gland to naturally elevate growth hormone levels, supporting muscle development, fat reduction, and recovery. Unlike many other GHRPs, triggers GH release without significantly increasing cortisol or prolactin. Promotes the growth of lean muscle tissue, enhances fat-burning processes, and shortens recovery times. May also support better sleep and overall wellness by aligning with the body’s natural GH rhythm.

  1. Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. PMID: 9849822 | DOI: 10.1530/eje.0.1390552
  2. Lu Z, et al. The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism. Physiol Behav. 2024;284:114644. PMID: 39043357 | DOI: 10.1016/j.physbeh.2024.114644
  3. Aagaard NK, et al. Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid treated rats. Growth Horm IGF Res. 2009;19(5):426-431. PMID: 19231263 | DOI: 10.1016/j.ghir.2009.01.001

Certificate of Analysis

Laboratory finding: Quantity 8.188 mg against a 10 mg label; report flags -18.1%. Original laboratory report for Ipamorelin. Product and labeled strength matched. Vial lot/current-stock association has not been confirmed. Refer to the original report for laboratory findings.

Verify this batch

Print or download (PDF)

Serial: COA-1001269-A0YV · Integrity verified